Juvenile Dermatomyositis-Clinical Phenotypes.
Li D, Tansley SL.
Curr Rheumatol Rep. 2019 Dec 11;21(12):74. doi: 10.1007/s11926-019-0871-4.
Dermatomyositis.
O'Connell KA, LaChance AH.
N Engl J Med. 2021 Jun 24;384(25):2437. doi: 10.1056/NEJMicm2033425.
Juvenile dermatomyositis. Where are we now?
McCann LJ, Livermore P, Wilkinson MGL, Wedderburn LR.
Clin Exp Rheumatol. 2022 Feb;40(2):394-403. doi: 10.55563/clinexprheumatol/56ilob. Epub 2022 Feb 7.
Dermatomyositis.
Chu LL, Rohekar G.
CMAJ. 2019 Mar 25;191(12):E340. doi: 10.1503/cmaj.180947.
Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management.
Leung AKC, Lam JM, Alobaida S, Leong KF, Wong AHC.
Curr Pediatr Rev. 2021;17(4):273-287. doi: 10.2174/1573396317666210426105045.
[Anti-MDA5 dermatomyositis. Literature review].
Castro-Molina SA, Méndez-Flores S.
Rev Med Inst Mex Seguro Soc. 2023 Jan 2;61(1):99-105.
Current diagnosis and treatment of polymyositis and dermatomyositis.
Sasaki H, Kohsaka H.
Mod Rheumatol. 2018 Nov;28(6):913-921. doi: 10.1080/14397595.2018.1467257. Epub 2018 May 9.
Paraneoplastic Dermatomyositis.
Orton C, Topham C, Madigan LM.
Am J Med. 2022 Aug;135(8):969-971. doi: 10.1016/j.amjmed.2022.01.016. Epub 2022 Feb 24.
Dermatomyositis.
Mahil S, Marks D, McCormack M, Rahman A.
Br J Hosp Med (Lond). 2012 Feb;73(2):C18-22. doi: 10.12968/hmed.2012.73.sup2.c18.
[Dermatomyositis-update].
Volc-Platzer B.
Hautarzt. 2015 Aug;66(8):604-10. doi: 10.1007/s00105-015-3659-0.
